Trandolapril Tabs4 mg / 100 Count
Back to Products
Brand name: Mavik®
Trandolapril tablets USP are indicated for the treatment of hypertension. They may be used alone or in combination with other antihypertensive medication such as hydrochlorothiazide.
Heart Failure Post Myocardial Infarction or Left-Ventricular Dysfunction Post Myocardial Infarction
Trandolapril tablets USP are indicated in stable patients who have evidence of left-ventricular systolic dysfunction (identified by wall motion abnormalities) or who are symptomatic from congestive heart failure within the first few days after sustaining acute myocardial infarction. Administration of trandolapril to Caucasian patients has been shown to decrease the risk of death (principally cardiovascular death) and to decrease the risk of heart failure-related hospitalization (see CLINICAL PHARMACOLOGY – Heart Failure or Left-Ventricular Dysfunction Post Myocardial Infarction for details of the survival trial).
For more information please see the prescribing information on DailyMed.
|Product Name||Trandolapril Tabs|
|Pack Size||100 Count|
|Gluten||Free from Gluten|
|Sweeteners||Free from Sweeteners|
|Soy||Free from Soy|
|Gelatin||Free from Gelatin|
|Allergen Info||Not Applicable|
|Other Product Info||Not Applicable|
Lactose monohydrate, corn starch, croscarmellose sodium, hypromellose 2910, povidone k30, sodium stearyl fumarate, ferric oxide red.
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
|Product Shelf Life||24 Months|
*The brand names listed are not owned by Rising Pharma. Rising Pharma products are generic equivalents to the respective brand names listed on this website.